Healthcare >> CEO Interviews >> December 13, 1999
DR DAVID CHISWELL is the founder and Chief Executive Officer of
Cambridge Antibody Technology Group Plc. He has been responsible for
operational management since foundation and was appointed a director in
December 1995. Previously, he spent nine years at Amersham
International Plc where he held a number of posts combining
responsibilities for product development and research management. Prior
to moving into the commercial sector in 1981, he gained research
experience in the field of molecular retrovirology at the MRC Institute
of Virology in Glasgow, the department of Immunology and Microbiology at
UCLA in California and the department of Tumour Virology at the Imperial
Cancer Research Fund in London. Profile
history, and then can you bring us up to date as to what you see as the
company and your business today.
Dr. Chiswell:
